These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4544912)

  • 21. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of new nystatin and polyfungin derivatives as compared to original antibiotics on Candida strains isolated from patients with recurrent mycoses.
    Kwaśniewska J
    Mater Med Pol; 1988; 20(4):233-7. PubMed ID: 3249541
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method.
    Pai MP; Jones AL; Mullen CK
    Diagn Microbiol Infect Dis; 2007 May; 58(1):129-32. PubMed ID: 17240112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
    Citak S; Ozçelik B; Cesur S; Abbasoğlu U
    Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on clinical antifungal susceptibility testing for Candida species.
    Lewis RE; Klepser ME; Pfaller MA
    Pharmacotherapy; 1998; 18(3):509-15. PubMed ID: 9620102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimycotic activity of Myrtus communis L. towards Candida spp. from isolates.
    Cannas S; Molicotti P; Ruggeri M; Cubeddu M; Sanguinetti M; Marongiu B; Zanetti S
    J Infect Dev Ctries; 2013 Mar; 7(3):295-8. PubMed ID: 23493012
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fungal infections: involved species and minimal inhibitory concentrations of common antifungal agents].
    Dei-Cas E; Fruit J; Poulain D; Dutoit E; Chendid H; Vernes A
    Ann Biol Clin (Paris); 1984; 42(6):415-8. PubMed ID: 6543419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.
    Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)
    Clin Microbiol Infect; 2008 Apr; 14(4):398-405. PubMed ID: 18190574
    [No Abstract]   [Full Text] [Related]  

  • 32. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
    Nawrot U; Nowicka J; Juszczak K; Gusin B
    Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yeast from burn patients at a major burn centre of China.
    Luo G; Peng Y; Yuan Z; Cheng W; Wu J; Fitzgerald M
    Burns; 2011 Mar; 37(2):299-303. PubMed ID: 20434270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofilm formation by Candida species on intrauretheral catheter and its antifungal susceptibility profile.
    Chaudhary S; Gupta C; Das S; Saha R; Rani M; Ramachandran VG
    Indian J Med Microbiol; 2014; 32(4):467-8. PubMed ID: 25297047
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
    Schönebeck J; Anséhn S
    Sabouraudia; 1973 Mar; 11(1):10-20. PubMed ID: 4574129
    [No Abstract]   [Full Text] [Related]  

  • 38. Hamycin in pulmonary mycoses--complicated tuberculosis.
    Thirumalachar MJ; Shende GY
    Hindustan Antibiot Bull; 1973 May; 15(4):141-4. PubMed ID: 4543505
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro evaluation of natamycin sensitivity of Candida and Torulopsis glabrata strains isolated from the genital tract].
    Merkel M; Kretowicz J
    Pol Tyg Lek; 1985 Mar; 40(9):257-8. PubMed ID: 3873649
    [No Abstract]   [Full Text] [Related]  

  • 40. [Skin and mucosal candidiasis. Typification of species isolated from a limited caseload and in vitro study of the activity of some antifungal drugs on isolated strains].
    Pezzarossa E; Bossano A; Cervetti O; Forte M; Mele M
    G Ital Dermatol Venereol; 1988 Dec; 123(12):665-9. PubMed ID: 3253188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.